BiotechTube
Home/InflaRx/Dr. Igor Orshanskiy
DI

Dr. Igor Orshanskiy

Senior Director, Head of Business Development

InflaRx

Therapeutic Areas

Inflammatory DiseasesCritical CareImmunology

InflaRx Pipeline

DrugIndicationPhase
Vilobelimab (GOHIBIC)Critical COVID-19 (SARS-CoV-2-induced ARDS)Marketed (EUA)
VilobelimabPyoderma GangrenosumPhase 3
Izicopan (IFX-4)Inflammatory DiseasesPreclinical
IFX002Inflammatory DiseasesPreclinical

Leadership Team at InflaRx

PD
Prof. Dr. Niels C. Riedemann
Chief Executive Officer and Founder
PR
Prof. Renfeng Guo, M.D.
Chief Scientific Officer and Founder
DT
Dr. Thomas Taapken
Chief Financial Officer
CC
Camilla Chong, M.D.
Chief Medical Officer
JM
Jan Medina, CFA
Vice President, Head of Investor Relations
DO
Derval O’Carroll
Senior Vice President, Global Head of Regulatory Affairs & Compliance
NF
Nicolas Fulpius
Chairman of the Board
View full InflaRx profile